Klotho Neurosciences公司宣布,其针对人类Klotho基因序列中分泌型Klotho蛋白("S-Kl")异构体的成分与用途专利主张,已成功获得澳大利亚专利局的授权。这一进展标志着该公司在开发基于Klotho蛋白的创新疗法方面取得了重要的知识产权保护。
Klotho Neurosciences公司宣布,其针对人类Klotho基因序列中分泌型Klotho蛋白("S-Kl")异构体的成分与用途专利主张,已成功获得澳大利亚专利局的授权。这一进展标志着该公司在开发基于Klotho蛋白的创新疗法方面取得了重要的知识产权保护。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.